Acurx Pharmaceuticals, Inc.
ACXP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001736243
No open-market purchases or sales by Acurx Pharmaceuticals, Inc. insiders were filed in the last 90 days; 18 institutions reported holding it in 13F filings for Q2 2026, worth $185.5K in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in Acurx Pharmaceuticals, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 13
- +1 vs. Q1 2023
- Shares held
- 1.49M
- +946.4K (+175.7%) vs. Q1 2023
- Total value
- $3.94M
- +$2.07M (+111.3%) vs. Q1 2023
- New holders
- 3
- 6 more added
- Sold out
- 2
- 1 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ACXP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 18 | $185.5K |
| Q1 2026 | 21 | $674.2K |
| Q4 2025 | 18 | $345.2K |
| Q3 2025 | 16 | $241.5K |
| Q2 2025 | 32 | $1.33M |
| Q1 2025 | 24 | $1.36M |
| Q4 2024 | 26 | $1.15M |
| Q3 2024 | 22 | $2.41M |
| Q2 2024 | 25 | $2.71M |
| Q1 2024 | 26 | $3.05M |
| Q4 2023 | 23 | $4.18M |
| Q3 2023 | 18 | $1.32M |
| Q2 2023 | 13 | $3.94M |
| Q1 2023 | 12 | $1.86M |
| Q4 2022 | 14 | $5.27M |
| Q3 2022 | 14 | $4.66M |
| Q2 2022 | 12 | $1.43M |
| Q1 2022 | 9 | $1.15M |
| Q4 2021 | 11 | $455.3K |
| Q3 2021 | 8 | $332.0K |
| Q2 2021 | 3 | $163.0K |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Acurx Pharmaceuticals, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Armistice Capital, LLC | 1,182,000 | $3.13M | 0.08% | +902,000+322.1% | Added |
| Vanguard Group Inc | 121,044 | $320.8K | 0.00% | +31,559+35.3% | Added |
| Geode Capital Management, LLC | 77,283 | $204.8K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 22,000 | $58.3K | 0.00% | +6,000+37.5% | Added |
| BlackRock Inc. | 18,875 | $50.0K | 0.00% | +2,714+16.8% | Added |
| TD Waterhouse Canada Inc. | 18,656 | $49.4K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 17,308 | $45.9K | 0.00% | −4,743−21.5% | Reduced |
| One68 Global Capital, LLC | 13,044 | $34.6K | 0.21% | +13,044 | New |
| Tocqueville Asset Management L.P. | 10,100 | $26.8K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 4,445 | $11.8K | 0.00% | +1,555+53.8% | Added |
| Salem Investment Counselors Inc | 100 | $265 | 0.00% | +100 | New |
| Wells Fargo & Company | 65 | $172 | 0.00% | +3+4.8% | Added |
| Royal Bank of Canada | 121 | $0 | 0.00% | +121 | New |
| Belpointe Asset Management LLC | 0 | $0 | 0.00% | −3,000−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −2,904−100.0% | Sold out |